CYP 3.85% 25.0¢ cynata therapeutics limited

Another high level appointment ex CSL. Last 7 + years with...

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Another high level appointment ex CSL. Last 7 + years with CSL.

    Highlights:

    • Former senior clinical position with CSL Limited in clinical development

    • Dr Airey brings over 25 years’ experience in respiratory, rheumatology, dermatology, biologicals, international markets and listed companies and is a highly experienced clinician

    • Appointment is consistent with Cynata’s growing clinical trial activities and late-stage clinical product portfolio


    "Dr Airey is an accomplished biopharmaceutical executive and physician with broad international experience in the successful development and commercialisation of pharmaceutical products including novel biological agents. She has been involved in the design and execution of multiple clinical trials from early through to late stage, encompassing a wide range of therapeutic categories in multiple geographies. Dr Airey is expected to join Cynata in October from CSL Limited where she is currently Director, Translational Development. Previously Dr Airey was a Clinical Development Physician at Seqirus, a CSL company, and earlier held a range of medical positions within biotech, pharmaceutical and clinical research companies.
    Her career path has led to her playing important roles in the market approvals of several drug products."
    Last edited by Sector: 26/07/21
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.010(3.85%)
Mkt cap ! $44.90M
Open High Low Value Volume
26.0¢ 26.5¢ 25.0¢ $5.869K 22.42K

Buyers (Bids)

No. Vol. Price($)
1 29342 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 30000 1
View Market Depth
Last trade - 15.47pm 11/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.